Sarno S - Search Results

1

Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.

Cozza G, Bonvini P, Zorzi E, Poletto G, Pagano MA, Sarno S, Donella-Deana A, Zagotto G, Rosolen A, Pinna LA, Meggio F, Moro S. Cozza G, et al. Among authors: sarno s. J Med Chem. 2006 Apr 20;49(8):2363-6. doi: 10.1021/jm060112m. J Med Chem. 2006. PMID: 16610779

2

Unique activation mechanism of protein kinase CK2. The N-terminal segment is essential for constitutive activity of the catalytic subunit but not of the holoenzyme.

Sarno S, Ghisellini P, Pinna LA. Sarno S, et al. J Biol Chem. 2002 Jun 21;277(25):22509-14. doi: 10.1074/jbc.M200486200. Epub 2002 Apr 15. J Biol Chem. 2002. PMID: 11956194 Free article.

3

Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight.

De Moliner E, Moro S, Sarno S, Zagotto G, Zanotti G, Pinna LA, Battistutta R. De Moliner E, et al. Among authors: sarno s. J Biol Chem. 2003 Jan 17;278(3):1831-6. doi: 10.1074/jbc.M209367200. Epub 2002 Nov 4. J Biol Chem. 2003. PMID: 12419810 Free article.

4

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

Sarno S, de Moliner E, Ruzzene M, Pagano MA, Battistutta R, Bain J, Fabbro D, Schoepfer J, Elliott M, Furet P, Meggio F, Zanotti G, Pinna LA. Sarno S, et al. Biochem J. 2003 Sep 15;374(Pt 3):639-46. doi: 10.1042/BJ20030674. Biochem J. 2003. PMID: 12816539 Free PMC article.

5

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.

Meggio F, Pagano MA, Moro S, Zagotto G, Ruzzene M, Sarno S, Cozza G, Bain J, Elliott M, Deana AD, Brunati AM, Pinna LA. Meggio F, et al. Among authors: sarno s. Biochemistry. 2004 Oct 12;43(40):12931-6. doi: 10.1021/bi048999g. Biochemistry. 2004. PMID: 15461466 Free article.

6

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.

Pagano MA, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, Bain J, Elliott M, Meggio F, Kazimierczuk Z, Pinna LA. Pagano MA, et al. Among authors: sarno s. J Med Chem. 2004 Dec 2;47(25):6239-47. doi: 10.1021/jm049854a. J Med Chem. 2004. PMID: 15566294

7

Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.

Battistutta R, Mazzorana M, Sarno S, Kazimierczuk Z, Zanotti G, Pinna LA. Battistutta R, et al. Among authors: sarno s. Chem Biol. 2005 Nov;12(11):1211-9. doi: 10.1016/j.chembiol.2005.08.015. Chem Biol. 2005. PMID: 16298300

8

Autophosphorylation at the regulatory beta subunit reflects the supramolecular organization of protein kinase CK2.

Pagano MA, Sarno S, Poletto G, Cozza G, Pinna LA, Meggio F. Pagano MA, et al. Among authors: sarno s. Mol Cell Biochem. 2005 Jun;274(1-2):23-9. doi: 10.1007/s11010-005-3116-y. Mol Cell Biochem. 2005. PMID: 16335525

9

Development and exploitation of CK2 inhibitors.

Sarno S, Ruzzene M, Frascella P, Pagano MA, Meggio F, Zambon A, Mazzorana M, Di Maira G, Lucchini V, Pinna LA. Sarno S, et al. Mol Cell Biochem. 2005 Jun;274(1-2):69-76. doi: 10.1007/s11010-005-3079-z. Mol Cell Biochem. 2005. PMID: 16335530

10

Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.

Salvi M, Sarno S, Marin O, Meggio F, Itarte E, Pinna LA. Salvi M, et al. Among authors: sarno s. FEBS Lett. 2006 Jul 10;580(16):3948-52. doi: 10.1016/j.febslet.2006.06.031. Epub 2006 Jun 21. FEBS Lett. 2006. PMID: 16806200 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters